Hypoglycemia in Diabetes Mellitus

Hypoglycemia in Diabetes Mellitus occurs when blood sugar levels drop too low, affecting the body's ability to provide energy to cells, especially in the brain. This condition involves the endocrine system, specifically the regulation of glucose by insulin and other hormones. People with diabetes are at risk because their treatment often includes insulin or medications that lower blood sugar. Symptoms can include shaking, sweating, confusion, and dizziness, which result from the brain not getting enough glucose. Severe hypoglycemia can lead to seizures, loss of consciousness, or even death if not promptly treated. It is a common and serious complication that requires careful monitoring of blood sugar levels. Understanding this condition helps in recognizing early warning signs and preventing dangerous episodes.

Hypoglycemia in Diabetes Mellitus is defined as a blood glucose level below 70 mg/dL caused primarily by an imbalance between insulin administration or endogenous insulin secretion and glucose availability. It is most commonly due to exogenous insulin overdose, sulfonylurea use, or missed meals in patients treated for diabetes. The core pathology involves excessive insulin action leading to increased glucose uptake by tissues and suppressed hepatic glucose production. Clinically, it manifests with autonomic symptoms (e.g., tremor, palpitations) and neuroglycopenic symptoms (e.g., confusion, seizures) due to brain glucose deprivation. This condition is significant because recurrent hypoglycemia can impair counterregulatory hormone responses and increase the risk of severe episodes. Recognition and prevention are critical to avoid morbidity and mortality in diabetic patients.